The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.622
Bid: 1.622
Ask: 1.678
Change: 0.065 (4.10%)
Spread: 0.056 (3.453%)
Open: 1.648
High: 1.68
Low: 1.622
Prev. Close: 1.585
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Asimilar and Worldsec swing to profit

Fri, 30th Apr 2021 16:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Asimilar Group PLC - investment firm focused on big data, machine learning, telematics and the internet of things - For the six months ended March 31, swings to pretax profit of GBP23.4 million from loss of GBP565,583 the year before, through a gain of GBP21.8 million following the remeasurement of assets to fair value. Revenue remained unchanged year-on-year at GBP7,000. For the year ended September 30, 2020, company swings to pretax profit of GBP392,329 from loss of GBP731,784, while revenue remains flat at GBP14,000.

----------

Worldsec Ltd - South East Asia-focused investment company - For 2020, swings to pretax profit of USD944,000 from loss of USD704,000 the year before, due to a positive change in the fair value of the group's holdings in Homaer Class D shares driven by an increased value of the investment in Bytedance. Revenue however declined 31% year-on-year to USD96,000 from USD140,000, due to a lack of interest income.

----------

UP Global Sourcing Holdings PLC - Oldham, Greater Manchester-based consumer brands owner trading as Ultimate Products - For the six months ended January 31, pretax profit up 19% at GBP7.2 million from GBP6.0 million the year before, on revenue which grew 11% year-on-year to GBP75.4 million from GBP67.7 million, due to strong performances from Supermarkets and the group's online business. Declares interim dividend of 1.69 pence per share, up 46% from 1.16p the prior year. Looking ahead, expects annual underlying pretax profit in excess of GBP10.8 million, and revenue to be in excess of GBP135 million, up from GBP115.7 million the prior year.

----------

FireAngel Safety Technology Group PLC - Coventry-based home safety products maker - For 2020, pretax loss narrows at GBP9.3 million from GBP11.0 million the year before, in spite of 12% decline in revenue to GBP39.9 million from GBP45.5 million, driven by a fall in sales due to the effect of Covid-19 lockdowns on customer demand. Looking ahead, targets improved performance for 2021 following a good start to the year. FireAngel is looking to raise GBP9.8 million through a placing of 51.4 million shares at 18p each and GBP6.9 million via an open offer on the basis of 10 new shares for every 33 existing shares held. Proceeds will go towards funding research and development to accelerate new products. Appoints Zoe Fox, finance director of subsidiary FireAngel Safety Technology Ltd has been appointed group chief financial officer, replacing Jon Kempster.

----------

Blackstone Loan Financing Ltd - floating rate senior secured loans and bonds investment fund - As at December 31, net asset value per share up at EUR0.8557 from EUR0.8543 the same date the year before. Share price at the end of 2020 was EUR0.67 reflecting a 22% discount to net asset value. Declares dividend of EUR0.07 per share, down from EUR0.10 the prior year.

----------

Keystone Positive Change Investment Trust PLC - invests in UK stocks - For six months ended March 30, net asset value total return is minus 0.9%, compared to a positive 14.2% total return from the comparative index, comprising the FTSE All-Share index up to February 10 and the MSCI All Country World Index afterwards. Net asset value per share as at March 31 at 297.39 pence, down from 305.80p at the end of September 2020.

----------

Westminster Group PLC - Banbury-based security services provider - For 2020, pretax loss narrows to GBP761,000 from GBP1.3 million due to a drop in administrative expenses, despite a dip in revenue to GBP9.9 million from GBP10.9 million, due to a considerable decline in Managed Services. Looking ahead, outlook for 2021 is positive following a strong start. Expects pretax profit and revenue for 2021 to meet market expectations.

----------

AIQ Ltd - Cayman Islands-based firm focused on acquiring and developing e-commerce sector businesses - For year ended October 31, net loss widens to GBP3.6 million from GBP500,000 the year before, following the writing off of the investment in Alchemist Codes Sdn Bhd, which was acquired in March 2020. However, generates revenue of GBP154,649 from none the prior year, due to the sale of software products and maintenance income. Looking ahead, will focus on completing strategic review to assess the viability of Alchemist Codes.

----------

Tekcapital PLC - UK intellectual property investment company - As at November 30, net assets rise 45% year-on-year to USD32.7 million from USD22.5 million the same date the year before, as the value of the group's portfolio rises to USD30.5 million from USD20.3 million. For the year, pretax profit rises to GBP7.7 million from USD7.7 million from USD5.5 million, driven by revenue growth to USD9.9 million from USD7.7 million.

----------

Minoan Group PLC - developer of a holiday resort in Greece - For year ended October 31, pretax loss narrows to GBP876,000 from GBP2.1 million, due to the cancellation of warrants, leading to a credit rather than a charge for share-based payments. Looking ahead, has continued to prepare and progress the project in Crete, refinancing its indebtedness during the period.

----------

Greencare Capital PLC - cannabis sector-focused investment firm - for the 13 months ended October 31, posts pretax loss of GBP427,000. During period, makes two investments into Clearly Supplements Ltd and Voyager Life Ltd. Looking ahead, expects significant growth from the CBD sector in the short term.

----------

Honeycomb Investment Trust PLC - London-based investor in credit assets originated by non-bank lending platforms - As at December 31, net asset value per share dips to 1,013 pence from 1,015p the same date the year before, while net assets dropped to GBP357.2 million from GBP400.4 million. Declares dividend of 80.0p per share, in line with the year before.

----------

Scotgold Resources Ltd - gold exploration and production company focused on Scotland - For the six months ended December 31, pretax loss widens to AUD2.4 million from AUD1.3 million the year before, due to lower interest income and a lack of grants received in the prior year. Looking ahead, expects output from Cononish project for calendar year 2021 to be less than company's guidance range, as ramp up of underground mining production is set to be slower than originally planned.

----------

Midatech Pharma PLC - Cardiff-based drug delivery technology company - For 2020, pretax loss widens to GBP23.5 million from GBP10.9 million the year before, following a GBP12.4 million impairment charge after terminating the development of MTD201 and goodwill arising from the acquisition of Q Chip Ltd in 2014. Revenue meanwhile declined 49% year-on-year to GBP343,000 from GBP674,000.

----------

Iconic Labs PLC - London-based media and technology business - For the six months ended December 31, pretax loss widens to GBP934,707 from GBP762,130 a year prior due to rising consulting, legal and professional costs, more than offsetting sharp growth in revenue to GBP496,052 from GBP2,500 through the supply of management services to business partners.

----------

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - For 2020, pretax loss widens to GBP2.1 million from GBP1.5 million the year before, due to higher administrative costs, particularly in legal feels and laboratory expenses. Generates no revenue, in line with the prior year.

----------

Wildcat Petroleum PLC - seeking investment opportunities in upstream petroleum - For period from January 8 to Dec 31, posts maiden pretax loss of GBP67,000, due to administrative and listing costs. Looking ahead, reports progress in sourcing a potential oil asset.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 12:19

EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:04

Hemogenyx Pharmaceuticals raises money for leukaemia treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing.

Read more
16 Feb 2024 11:27

Hemogenyx shares rise on potential for CBR to treat brain diseases

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be delivered into the brain through programmed microglial cells and could be used for the treatment of brain cancers and some neurodegenerative diseases.

Read more
14 Feb 2024 10:14

Hemogenyx says CBR can be used intranasally to treat viral infections

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form of messenger RNA for the "potential" treatment of airborne viral infections.

Read more
9 Feb 2024 10:00

IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug Administration has lifted clinical hold on company's investigational new drug application for Hemo-Car-T to treat acute myeloid leukemia. FDA placed therapy on clinical hold in July due to a splicing deficiency during manufacture of the lentivirus used to produce Car-T cells. Hemogenyx in August produced a "detailed plan, supported by laboratory tests" to address FDA's concerns, which was accepted the following month.

Read more
2 Feb 2024 10:44

IN BRIEF: Hemogenyx hails US patent application progress

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - Celebrates as patent application is allowed by the US Patent & Trademark Office. The patent is for the process of eliminating hematopoietic stem cells or hematopoietic progenitors in a patient using bi-specific antibodies.

Read more
16 Jan 2024 11:13

Hemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDA

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it submitted a complete response to the previously announced clinical hold of the investigational new drug application to the US Food & Drug Administration.

Read more
8 Jan 2024 10:56

Hemogenyx Pharmaceuticals completes process qualification run

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it completed a process qualification run.

Read more
28 Nov 2023 16:53

TRADING UPDATES: Upland Resources completes technical study at Sarawak

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Nov 2023 10:52

Hemogenyx shares up as says CBR platform a potential cancer treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said its chimeric based receptor platform could "potentially" be used to treat cancer and viral diseases.

Read more
15 Nov 2023 15:43

Hemogenyx Pharmaceuticals completes lentivirus re-manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said it has completed the re-manufacturing of an improved lentivirus devoid of splice variants.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Sep 2023 14:37

TRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells Questers

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Sep 2023 13:00

Hermogenyx shares soar on new partnership with Prevail Partners

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Read more
14 Sep 2023 14:31

Hemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift plan

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said the US Food & Drug Administration has accepted its plan to address concerns which sparked a clinical hold on its chimeric antigen receptor T-cell or Hemo-Car-T therapy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.